Rosalba Benvenuto

Learn More
OBJECTIVES The interferon-alpha (IFN-alpha) therapy for HCV hepatitis may exacerbate or induce underlying thyroid disorders. Besides viral factors, the human leukocyte antigen (HLA) may be an independent risk factor. METHODS We evaluated fifteen patients with HCV chronic hepatitis during a period of 40 months. At the enrollment, all the patients were(More)